Literature DB >> 23690070

Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.

Rebecca Schneider Aguirre1, Saul J Karpen.   

Abstract

Retinoid X receptor α [RXRα; nuclear receptor (NR)2B1] is a crucial regulator in the expression of a broad array of hepatic genes under both normal and pathologic conditions. During inflammation, RXRα undergoes rapid post-translational modifications, including c-Jun N-terminal kinase (JNK)-mediated phosphorylation, which correlates with a reduction in RXRα function. A small ubiquitin-like modifier (SUMO) acceptor site was recently described in human RXRα, yet the contributors, regulators, and consequences of SUMO-RXRα are not well understood. Inflammation and other stressors alter nuclear receptor function in liver and induce SUMOylation of several NRs as part of proinflammatory gene regulation, but linkages between these two pathways in liver, or for RXRα directly, remain unexplored. We sought to determine if inflammation induces SUMOylation of RXRα in human liver-derived (HuH-7) cells. Lipopolysaccharide, interleukin-1β, and tumor necrosis factor α (TNFα) rapidly and substantially stimulated SUMOylation of RXRα. Two RXRα ligands, 9-cis retinoic acid (9cRA) and LG268, induced SUMOylation of RXRα, whereas both inflammation- and ligand-induced SUMOylation of RXRα require the K108 residue. Pretreatment with 1,9-pyrazoloanthrone (SP600125), a potent JNK inhibitor, abrogates TNFα- and 9cRA-stimulated RXRα SUMOylation. Pretreatment with SUMOylation inhibitors markedly augmented basal expression of several RXRα-regulated hepatobiliary genes. These results indicate that inflammatory signaling pathways rapidly induce SUMOylation of RXRα, adding to the repertoire of RXRα molecular species in the hepatocyte that respond to inflammation. SUMOylation, a newly described post-translational modification of RXRα, appears to contribute to the inflammation-induced reduction of RXRα-regulated gene expression in the liver that affects core hepatic functions, including hepatobiliary transport.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690070      PMCID: PMC3716323          DOI: 10.1124/mol.113.085555

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  52 in total

Review 1.  Functional genetic dissection of nuclear receptor signalling in obesity, diabetes and liver regeneration using spatiotemporally controlled somatic mutagenesis in the mouse.

Authors:  Takeshi Imai
Journal:  Keio J Med       Date:  2003-09

Review 2.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

3.  Structural determinants of allosteric ligand activation in RXR heterodimers.

Authors:  Andrew I Shulman; Christopher Larson; David J Mangelsdorf; Rama Ranganathan
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

4.  Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.

Authors:  Koren K Mann; Alessandra M S Padovani; Qi Guo; April L Colosimo; Ho-Young Lee; Jonathan M Kurie; Wilson H Miller
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

5.  Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver.

Authors:  Romi Ghose; Jaap Mulder; Richard J von Furstenberg; Sundararajah Thevananther; Folkert Kuipers; Saul J Karpen
Journal:  J Hepatol       Date:  2006-10-23       Impact factor: 25.083

6.  Pregnane X receptor is SUMOylated to repress the inflammatory response.

Authors:  Gang Hu; Chenshu Xu; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2010-08-18       Impact factor: 4.030

7.  Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands.

Authors:  Michael Macoritto; Loan Nguyen-Yamamoto; Dao Chao Huang; Sara Samuel; Xian Fang Yang; Tian Tian Wang; John H White; Richard Kremer
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

8.  Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis.

Authors:  Mitsumi Arito; Taro Horiba; Satoshi Hachimura; Jun Inoue; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2008-04-09       Impact factor: 5.157

Review 9.  Mechanisms of cytochrome P450 induction.

Authors:  Leslie M Tompkins; Andrew D Wallace
Journal:  J Biochem Mol Toxicol       Date:  2007       Impact factor: 3.642

Review 10.  Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.

Authors:  Jaap Mulder; Saul J Karpen; Uwe J F Tietge; Folkert Kuipers
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  13 in total

Review 1.  SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?

Authors:  Juliana B Hoppe; Christianne G Salbego; Helena Cimarosti
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 2.  SUMO: a (oxidative) stressed protein.

Authors:  Marco Feligioni; Robert Nisticò
Journal:  Neuromolecular Med       Date:  2013-09-20       Impact factor: 3.843

3.  A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45α mRNA stability.

Authors:  Dongyun Zhang; Yuguang Liang; Qipeng Xie; Guangxun Gao; Jinlong Wei; Haishan Huang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

4.  SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.

Authors:  Wenqi Cui; Mengxi Sun; Nadezhda Galeva; Todd D Williams; Yoshiaki Azuma; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2015-06-10       Impact factor: 3.922

5.  Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.

Authors:  Sylvester Jusu; John F Presley; Richard Kremer
Journal:  J Biol Chem       Date:  2016-11-16       Impact factor: 5.157

Review 6.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

Review 7.  Sumoylation of critical proteins in amyotrophic lateral sclerosis: emerging pathways of pathogenesis.

Authors:  Emily Foran; Lauren Rosenblum; Alexey I Bogush; Davide Trotti
Journal:  Neuromolecular Med       Date:  2013-09-24       Impact factor: 3.843

8.  Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis Gagnep. via retinoid X receptor/liver X receptor heterodimers.

Authors:  Wei Wang; Ken-Ichi Nakashima; Takao Hirai; Makoto Inoue
Journal:  J Nat Med       Date:  2019-01-17       Impact factor: 2.343

9.  14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.

Authors:  Manuela Mancini; Elisa Leo; Ken-Ichi Takemaru; Virginia Campi; Fausto Castagnetti; Simona Soverini; Caterina De Benedittis; Gianantonio Rosti; Michele Cavo; Maria Alessandra Santucci; Giovanni Martinelli
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 10.  SUMOylation in development and neurodegeneration.

Authors:  Tak-Yu Yau; Oscar Molina; Albert J Courey
Journal:  Development       Date:  2020-03-18       Impact factor: 6.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.